{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:40:24Z","timestamp":1784194824945,"version":"3.55.0"},"reference-count":18,"publisher":"Centers for Disease Control MMWR Office","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6618a6","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T14:46:26Z","timestamp":1494513986000},"page":"482-485","source":"Crossref","is-referenced-by-count":36,"title":["Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine"],"prefix":"10.15585","volume":"66","author":[{"given":"Karen K.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Reingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R1","doi-asserted-by":"publisher","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries.","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R2","unstructured":"CDC. Cholera and otherVibrioillness surveillance (COVIS). Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https:\/\/www.cdc.gov\/vibrio\/surveillance.html"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tmaid.2016.07.003","article-title":"Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR.","volume":"14","author":"Herzog","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine.","volume":"16","author":"Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R5","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.1016\/j.vaccine.2010.02.037","article-title":"The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).","volume":"28","author":"Smith","year":"2010","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R6","unstructured":"Chen WH, Cohen MB, Kirkpatrick BD, Single-dose live attenuated oral cholera vaccine (CVD 103-HGR) protects against cholera at 10 days following vaccination: results of aVibrio choleraeO1 El Tor Inaba challenge study. In: proceedings of the 63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, 2013. New Orleans, Louisiana. http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/363\/CN-01056363\/frame.html."},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R7","unstructured":"CDC. Obtaining and evaluating evidence with grading of recommendations, assessment, development and evaluation (GRADE) for lyophilized CVD 103-HgR vaccine. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/cholera-CVD-103-HgR.html"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R8","unstructured":"Advisory Committee on Immunization Practices. Summary Report, February 24, 2016. Atlanta, GA: US Department of Health and Human Services, CDC, Advisory Committee on Immunization Practices; 2016. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-2016-02.pdf, editor.2016"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/IAI.64.4.1454-1457.1996","article-title":"Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella Typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.","volume":"64","author":"Kollaritsch","year":"1996","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/S0950268814001186","article-title":"Cholera in the United States, 2001\u20132011: a reflection of patterns of global epidemiology and travel.","volume":"143","author":"Loharikar","year":"2015","journal-title":"Epidemiol Infect"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1708-8305.2012.00607.x","article-title":"A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010.","volume":"19","author":"Haus-Cheymol","year":"2012","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jtm.12075","article-title":"Diarrheal illness among US residents providing medical services in Haiti during the cholera epidemic, 2010 to 2011.","volume":"21","author":"Schilling","year":"2014","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/clinids\/22.6.1108","article-title":"Cholera among Americans living in Peru.","volume":"22","author":"Taylor","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114050","article-title":"Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.","volume":"121","author":"Glass","year":"1985","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R17","first-page":"63","article-title":"A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.","volume":"76","author":"Perry","year":"1998","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.mm6618a6-201705111045-R18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/infdis\/168.5.1169","article-title":"Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.","volume":"168","author":"Simanjuntak","year":"1993","journal-title":"J Infect Dis"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T08:51:16Z","timestamp":1602060676000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/66\/wr\/mm6618a6.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":18,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2017,5,12]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6618a6","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,12]]},"published":{"date-parts":[[2017,5,12]]}}}